Ixazomib (MLN2238), 50mg

Ixazomib (MLN2238), 50mg

Ixazomib Citrate (MLN9708) Analogue, 5mg

Ixazomib Citrate (MLN9708) Analogue, 5mg

Ixazomib (MLN2238), 10mM/1mL

1.842,12 RON
SKU
SKM_S2180_10mM/1mL

Ixazomib (MLN2238) inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasomewith IC50and Kiof 3.4 nM and 0.93 nM in cell-free assays, respectively, also inhibits the caspase-like (β1) and trypsin-like (β2) proteolytic sites, with IC50 of 31 and 3500 nM. Ixazomib (MLN2238) induces autophagy. Phase 3.

Mai multe informatii
Price 1.548,00 RON (preturile sunt fara TVA)
Description

Ixazomib (MLN2238) inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasomewith IC50and Kiof 3.4 nM and 0.93 nM in cell-free assays, respectively, also inhibits the caspase-like (β1) and trypsin-like (β2) proteolytic sites, with IC50 of 31 and 3500 nM. Ixazomib (MLN2238) induces autophagy. Phase 3.